Particle.news

Download on the App Store

Dm Defends In-Store Health Services Pilot After Criticism From Medical Associations

Medical groups question the clinical validity of dm's retail health pilot.

Overview

  • dm is testing retinal photography with vision checks, AI skin assessments, tele‑dermatology consultations and blood tests in select locations and online through partner firms.
  • The company says ophthalmologists review retinal images and dermatology consults are handled by specialists, while the AI skin tool is presented as non‑diagnostic product guidance.
  • The ophthalmology and dermatology associations (BVA, BVDD) issued detailed critiques citing questionable standards, potential for misleading results, marketing concerns and added strain on specialist care.
  • BVDD president Ralph von Kiedrowski reports a self‑test of the online skin check that produced an incorrect “diagnosis” and prompted dm product recommendations.
  • Consumer advocates call for clearer advertising and validated outcomes; most services are paid (retinal photo plus vision check €14.95) while the AI skin analysis appears free, and competitors Müller and Rossmann are taking more cautious approaches.